Eton Pharmaceuticals (ETON) Total Debt (2019 - 2025)

Eton Pharmaceuticals (ETON) has 7 years of Total Debt data on file, last reported at $30.6 million in Q4 2025.

• For the quarter ending Q4 2025, Total Debt rose 2.51% year-over-year to $30.6 million; the trailing twelve-month figure through Dec 2025 stood at $30.6 million (up 2.51% YoY), and the FY2025 full-year result was $30.6 million, up 2.51% from the prior year.
• Total Debt improved to $30.6 million in Q4 2025, from $30.4 million in the prior quarter.
• In the past five years, Total Debt ranged from a high of $30.6 million in Q4 2025 to a low of $4.1 million in Q3 2024.
• A 5-year average of $12.0 million and a median of $6.4 million in 2022 frame the typical range for Total Debt.
• Across the five-year window, Total Debt retreated 28.1% in 2024 and jumped 636.17% in 2025, its largest moves.
• Tracing ETON's Total Debt over 5 years: stood at $6.7 million in 2021, then retreated by 3.94% to $6.4 million in 2022, then declined by 16.16% to $5.4 million in 2023, then jumped by 454.11% to $29.8 million in 2024, then gained by 2.51% to $30.6 million in 2025.
• Business Quant data shows ETON's Total Debt at $30.6 million in Q4 2025, $30.4 million in Q3 2025, and $30.2 million in Q2 2025.